These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 38243317

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
    Osuga Y, Enya K, Kudou K, Tanimoto M, Hoshiai H.
    Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
    Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA.
    Obstet Gynecol; 2022 Dec 01; 140(6):920-930. PubMed ID: 36357960
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
    Stewart EA, Lukes AS, Venturella R, Arjona Ferreira JC, Li Y, Hunsche E, Wagman RB, Al-Hendy A.
    Obstet Gynecol; 2022 Jun 01; 139(6):1070-1081. PubMed ID: 35675604
    [Abstract] [Full Text] [Related]

  • 10. Relugolix for the treatment of uterine fibroids.
    Rocca ML, Palumbo AR, Lico D, Fiorenza A, Bitonti G, D'Agostino S, Gallo C, Di Carlo C, Zullo F, Venturella R.
    Expert Opin Pharmacother; 2020 Oct 01; 21(14):1667-1674. PubMed ID: 32674616
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relugolix for the treatment of uterine fibroids.
    Barra F, Seca M, Della Corte L, Giampaolino P, Ferrero S.
    Drugs Today (Barc); 2019 Aug 01; 55(8):503-512. PubMed ID: 31461087
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-term administration of oral relugolix before single-port laparoscopic-assisted vaginal hysterectomy for symptomatic uterine myomas: A retrospective comparative study with leuprorelin injection.
    Takeda A.
    J Obstet Gynaecol Res; 2022 Jul 01; 48(7):1921-1929. PubMed ID: 35460303
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Presurgical treatment of uterine myomas with the GnRH-antagonist relugolix in combination therapy: an observational study.
    Muzii L, Galati G, Mercurio A, Olivieri C, Scarcella L, Azenkoud I, Tripodi R, Vignali M, Angioni S, Maiorana A.
    Sci Rep; 2024 Sep 28; 14(1):22481. PubMed ID: 39341875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.